Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 801 results for "amgen rank"

Allergan Moves Up In Market Cap Rank, Passing Amgen

Allergan Moves Up In Market Cap Rank, Passing Amgen

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Allergan PLC (AGN) has taken over the #36 spot from Amgen Inc (AMGN), according to The Online Investor. Click here to find out the top S&P 500 ... Franklin Credit Management Corporation, 4 days ago

5 images for amgen rank, 4 days ago, 4 days ago
Business First of Louisville, 3 months ago, 5 months ago, 5 months ago

Amgen (AMGN) Showing Resistance Near $163.53

After ThursdayaEUR(TM)s trading in Amgen Inc ( AMGN )'s patented algorithms uncovered a trade that offers a 6.96% return or 21.33% on an annualized basis (for comparison purposes only), while providing 3.65% downside ...
 TradingCharts.com1 week ago Amgen (AMGN) Trading Near $153.56 Support Level  TradingCharts.com2 weeks ago Potential Amgen (AMGN) Trade Has 3.39% Downside Protection  TradingCharts.com2 weeks ago Amgen (AMGN) Trading Near $154.19 Support Level  TradingCharts.com3 weeks ago

AstraZeneca, Amgen End Psoriasis Drug Brodalumab Deal - Analyst Blog

AstraZeneca plc AZN received disappointing news with Amgen AMGN announcing its intention to terminate the co-development and commercialization agreement with AstraZeneca for brodalumab due to safety issues. Amgen mentioned in its press release ...
 Yahoo! Finance1 month ago

Amgen (AMGN) Showing Bullish Technicals With Support At $163.31

MarketIntelligenceCenter.comaEUR(TM)s patented option-trade picking algorithm found two trade ideas on Amgen Inc ("AMGN) today after it traded between between $167.01 and $173.60 before closing at ...
 Individual.com2 months ago

VeloNews: Tour of California storylines

0 Shares Print Comment Now one of the longest-running international stage races in U.S. history, the Amgen Tour of California celebrates its 10th edition when it kicks off on Sunday in Sacramento. Launched in 2005 and first held in February ...
 ESPN.com1 month ago Ride the Amgen Tour of California with ZWIFT and Jensie!  Triathlonbusiness.com2 months ago

Amgen (AMGN) Showing Bearish Technicals With Resistance At $162.03

( via COMTEX) -- Amgen Inc ( AMGN ) presents a trading opportunity that offers a 5.78% return in just 56 days. A covered call on Amgen at the $165.00 level expiring on Aug. '15 offers an assigned return rate of 5.78% ...
 TradingCharts.com3 days ago

Amgen Presents Interim Data on Migraine Drug AMG 334

Amgen Inc. ( AMGN - Analyst Report ) presented encouraging 52-week interim results from the open-label extension phase II study on AMG 334, which is being evaluated for the prevention of episodic migraine. Data were presented at the annual meeting ...
 Zacks.com1 week ago

Amgen Cancer Drug Vectibix Hits Phase III Primary Endpoint

Amgen Inc. ( AMGN - Analyst Report ) announced that its cancer drug, Vectibix (panitumumab), met the primary endpoint in a phase III study ('0007). The global, multicenter, randomized, open-label study was conducted to assess the survival benefit ...
 Zacks.com1 week ago Pfizer's Cancer Drug Meets First Primary Endpoint in Phase III - Analyst Blog  Nasdaq2 months ago

Amgen adding 100 researchers in Cambridge as biotechs scout for 1,000-plus

While Amgen ($AMGN) has been busily chopping thousands of staffers throughout its organization while reducing its R&D budget, one of its goals in the restructuring--which was repeated in its 10Q earlier this week--was to beef up its presence in two ...
 FierceBiotech2 months ago Amgen Beats on Q1 Earnings & Revenues, Ups Earnings View - Analyst Blog  Zacks.com2 months ago Will Amgen (AMGN) Keep Earnings Streak Alive in 1Q? - Analyst Blog  Zacks.com2 months ago The Highest-Paid Golfers 2015  Forbes.com2 weeks ago

Amgen's Repatha Briefing Document Gives Mixed Review

Amgen Inc. 's ( AMGN - Analyst Report ) PCSK9 inhibitor, Repatha (evolocumab), is set to face the FDA's Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) on Jun 10, 2015. The FDA released briefing documents ahead of the advisory ...
 Zacks.com2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less